National Institute of Cardiology, Laranjeiras, Brazil   Report issue

Government Phase 1 Phase 4
Founded: Rio de Janeiro Brazil

Organization Overview

First Clinical Trial
2014
NCT02620995
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

National Institute of Cardiology, Laranjeiras, Brazil | National Institute of Cardiology - Ministry of Health -Brazil

Active Ingredients

Drugs in Phase 4 Trials (1)

sildenafil (viagra) (1 trial)

Drugs in Phase 1 Trials (2)

creatine (1 trial)

red beetroot (1 trial)

Drugs in Other Trials (5)

dexmedetomidine (precedex) (1 trial)

krill oil (1 trial)

phytosterol (1 trial)

sodium chloride (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 4)

Hyperhomocysteinemia (Phase 1)

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8